BRD4 and breast cancer: In a co-IP assay in human breast cancer MCF7 (Michigan Cancer Foundation-7) cells, we demonstrated that AR45 reduces binding affinity between AR and the master transcriptional regulator BRD4 (Bromodomain-containing protein 4) (Fig. 2I and fig.